Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
PLN 7M - 7M
Notice Type:
Contract Notice
Published Date:
08 September 2021
Closing Date:
11 October 2021
Location(s):
PL418 Poznański (PL Poland/POLSKA)
Description:
Successive purchases and delivery of medicines for Wielkopolska Rheumatological Center SP SZOZ in Śrem

Subjects of the order are Successive purchases and delivery of medicines for Wielkopolska Rheumatological Center SP SZOZ in Śrem

The object of the order is pharmaceutical products - medicines

The object of the order is pharmaceutical products - medicines.

Detailed description of the item includes the assortment and price set out in Annex 2.1 to SWZ

Successive Drug Purchases and Supplies to Drug Program — BARICYTINIB

Successive Drug Purchases and Supplies to Drug Program — BARICYTINIB

Detailed description of the item includes the assortment and price set out in Annex 2.10 to SWZ

Successive purchases and delivery of medicines to the drug program — SEKUKINUMAB

Successive purchases and delivery of medicines to the drug program — SEKUKINUMAB

Detailed description of the item includes the assortment and price set out in Annex 2.11 to SWZ

Successive Purchases and Delivery Immunoglobulin of Human Normal

Successive Purchases and Delivery Immunoglobulin of Human Normal

Detailed description of the item includes the assortment and price set out in Annex 2.12 to SWZ

Successive Drug Purchases and Supplies to Drug Program — UPADACITINIB

Successive Drug Purchases and Supplies to Drug Program — UPADACITINIB

Detailed description of the item includes the assortment and price set out in Annex 2.13 to SWZ

Successive Drug Purchases and Supplies to Drug Program — IKSEKIZUMAB

Successive Drug Purchases and Supplies to Drug Program — IKSEKIZUMAB

Detailed description of the item includes the assortment and price set out in Annex 2.14 to SWZ

Successive purchases and delivery of drugs to the drug program — ADALIMUMAB between 1.11.2021 and 31.12.2021

Successive purchases and delivery of drugs to the drug program — ADALIMUMAB between 1.11.2021 and 31.12.2021

Detailed description of the item includes the assortment and price set out in Annex 2.15 to SWZ

Successive purchases and supplies of medicines to the drug program — TOFACITINIB between 1.11.2021 and 31.12.2021

Successive purchases and supplies of medicines to the drug program — TOFACITINIB between 1.11.2021 and 31.12.2021

Detailed description of the item includes the assortment and price set out in Annex 2.16 to SWZ

Successive purchases and delivery of drugs to the drug program — TOCILIZUMAB.

Successive purchases and delivery of drugs to the drug program — TOCILIZUMAB.

Detailed description of the item includes the assortment and price set out in Annex 2.2 to SWZ

Successive Drug Purchases and Supplies to Drug Program — ETARNECEPT

Successive Drug Purchases and Supplies to Drug Program — ETARNECEPT

Detailed description of the item includes the assortment and price set out in Annex 2.3 to SWZ

Successive purchases and delivery of drugs to the drug program — CERTOLIZUMAB.

Successive purchases and delivery of drugs to the drug program — CERTOLIZUMAB.

Detailed description of the item includes the assortment and price set out in Annex 2.4 to SWZ

Successive purchases and delivery of drugs to the drug program — ADALIMUMAB.

Successive purchases and delivery of drugs to the drug program — ADALIMUMAB.

Detailed description of the item includes the assortment and price set out in Annex 2.5 to SWZ

Successive Drug Purchases and Supplies to Drug Program — RITUXYMAB

Successive Drug Purchases and Supplies to Drug Program — RITUXYMAB

Detailed description of the item includes the assortment and price set out in Annex 2.6 to SWZ

Successive Drug Purchases and Supplies to Drug Program — INFLIXIMAB

Successive Drug Purchases and Supplies to Drug Program — INFLIXIMAB

Detailed description of the item includes the assortment and price set out in Annex 2.7 to SWZ

Successive purchases and delivery of drugs to the drug program — GOLIMUMAB.

Successive Drug Purchases and Supplies to Drug Program — GOLIMUMAB

Detailed description of the item includes the assortment and price set out in Annex 2.8 to SWZ

Successive Drug Purchases and Supplies to Drug Program — TOFACITINIB

Successive Drug Purchases and Supplies to Drug Program — TOFACITINIB

Detailed description of the item includes the assortment and price set out in Annex 2.9 to SWZ

Download full details as .pdf
The Buyer:
WIELKOPOLSKI OSRODEK REUMATOLOGICZNY SP SZOZ w ŚREMIE
CPV Code(s):
33600000 - Pharmaceutical products